“Pharmacotherapies for AUD are highly underutilized. Only 8 percent of adults with AUD are currently being treated for the illness” with these medications, said Steven Batki, M.D., a professor of psychiatry at the University of California, San Francisco, who pointed out that there is no universal treatment that is as effective in all patients with AUD.